The UK Medicines and Healthcare products Regulatory Agency has issued guidance explaining when it may be appropriate for clinical trials to include patients previously treated with an advanced therapy medicinal product (ATMP).
Previous use of an ATMP – such as CAR-T cell therapy, gene and cell therapy products and tumor vaccines -...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?